Cylindromatosis (Turban Tumor Syndrome) (CYLD) (Intermediate Domain) Peptide
CYLD
Reactivity: Mouse, Rat
Host: Synthetic
BP, BI
-
- Target See all CYLD products
- CYLD (Cylindromatosis (Turban Tumor Syndrome) (CYLD))
- Protein Region
- Intermediate Domain
- Origin
- Mouse, Rat
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), BioImaging (BI)
- Characteristics
- CYLD peptide corresponds to 15 amino acids near the intermediate domain of CYLD.
-
-
- Application Notes
- CYLD Peptide is used for blocking the activity of CYLD antibody . The CYLD antibody ships at 0.5 mg/mL and the CYLD Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- CYLD peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.
- Storage
- -20 °C
- Storage Comment
- Store at -20°C. When reconstituted minimize freezing and thawing.
-
-
You are here:
